Related Experiment Videos
Pharmacokinetic optimisation of therapy with beta-adrenergic blocking agents
W H Frishman1, E J Lazar, G Gorodokin
1Department of Medicine Division, Albert Einstein College of Medicine, Bronx, New York.
Clinical Pharmacokinetics
|April 1, 1991
Summary
Beta-blockers are crucial for treating various conditions by blocking catecholamines. Individual beta-blocker drugs vary in how the body processes them, requiring personalized dosing for optimal clinical response.
Area of Science:
- Pharmacology
- Cardiovascular Medicine
- Drug Metabolism
Background:
- Beta-adrenergic blockade represents a significant pharmacotherapeutic advancement.
- Beta-blockers function by inhibiting catecholamine binding to beta-adrenergic receptors.
Purpose of the Study:
- To review the pharmacodynamic and pharmacokinetic differences among beta-blocking agents.
- To highlight the clinical significance of these inter-individual variations.
Main Methods:
- Review of existing literature on beta-blocker pharmacology and pharmacokinetics.
- Analysis of factors influencing drug absorption, metabolism, distribution, and excretion.
Main Results:
- Significant inter-individual variability exists in gastrointestinal absorption, hepatic metabolism, lipid solubility, protein binding, and renal clearance of beta-blockers.
- Factors such as race, age, smoking, and drug interactions can influence beta-blocker pharmacokinetics.
- Plasma drug concentrations are often unreliable for routine patient management due to wide interpatient variability.
Conclusions:
- Despite pharmacokinetic differences, beta-blockers require individualized titration to achieve desired clinical outcomes.
- Understanding these variations is crucial for effective patient management and optimizing therapeutic efficacy.